AMBER PARKER: Open Payments
NPI 1336871243 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 86 payments from 16 companies in 2025. Trend: 2023 $2,160 · 2024 $2,099 · 2025 $1,362
Food & beverage: $1,253Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $307 |
| Teva Pharmaceuticals USA, Inc. | 15 | $257 |
| Otsuka America Pharmaceutical, Inc. | 13 | $205 |
| E.R. Squibb & Sons, L.L.C. | 11 | $146 |
| Alkermes, Inc. | 6 | $118 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $47 |
| Medical Device Business Services, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
Products named: VRAYLAR, REXULTI, COBENFY, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, UZEDY.
Industry payments across PA — which companies pay providers there.
